Health & Wellness

Atlantic Health Among Six Regional Health Systems Forming Clinical Research Consortium

e853a04dbe16aeaf2c33_eb1e7935f7992f521974_image1-8.jpg
Brian Gragnolati, president and CEO of Atlantic Health System, speaks during press conference announcing the formation of The PIER Consortium. Credits: Atlantic Health System
e853a04dbe16aeaf2c33_eb1e7935f7992f521974_image1-8.jpg

PHILADELPHIA - Seeking to bring clinical trials and innovations in medicine even closer to home, Atlantic Health System, parent company of Summit's Overlook Medical Center, is now part of a group of six regional health systems that are founding members of a nonprofit clinical research consortium – Partners in Innovation, Education, and Research (PIER Consortium) – a streamlined clinical trial system that will span New Jersey and Pennsylvania.  

In addition to Atlantic Health System, other founding members of PIER Consortium include Drexel University, Einstein Healthcare Network, Geisinger including AtlantiCare, Main Line Health and Thomas Jefferson University.

“Research and innovation are among the key drivers of excellence and quality outcomes in patient care,” said Brian Gragnolati, president and CEO of Atlantic Health System. “Through the consortium, we are now able to move beyond geographic boundaries, expanding access to our own groundbreaking research while connecting our patients to exciting advancements from our PIER partners. This will have profound benefits for both researchers and patients.”

Sign Up for E-News

Clinical trials have traditionally been offered at academic medical centers and through affiliated hospitals to ensure patients are treated safely and effectively with the best standard of care. Unfortunately for patients, this can mean traveling many miles, sometimes across the country, for novel treatment. The PIER Consortium will bring clinical trial sites to larger numbers of patients, while also bringing new treatments to market faster.

“The concept for creating a world-class, collaborative, clinical research network of regional health institutions began in 2013 with the arrival of Steve Klasko, as Jefferson’s President and Chief Executive Officer,” said David Whellan, MD, Senior Associate Provost for Clinical Research at Jefferson and Chief Operating Officer of PIER. “Our vision is to advance patient care in the moment and improve quality of life and outcomes in the future.”

The goal of having a broad network of physician-researchers is to speed up the clinical trial process and deliver effective therapies to patients sooner. “It can take decades to prove a medication or other treatment is safe and effective for a particular disease, which can be too late for many patients seeking treatment,” added Dr. Whellan.

An estimated 80 percent of clinical trials fail to finish on time. Having contracts in place and physicians identified could allow trials to both start and reach participation capacity more quickly. The expertise shared across sites through PIER will allow clinical researchers to enroll patients in trials more quickly, and streamline the clinical trial process across institutions. This will create a more effective process for patients, trial sponsors, and researchers.

“PIER offers turn-key solutions with one contract and a single Institutional Review Board (IRB). With physician champions at each site, start-up activities will be coordinated to help each site hit the ground running,” said Dr. Whellan.

 

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

Flemington/Raritan

Proposal for Flemington Candidates' Forum

July 17, 2018

To The editor,

This is an open note to Flemington Mayoral candidates Phil Greiner and Betsy Driver; and Borough Council candidates  Marc Hain, Brooke Warden, Chris Runion Caitlin Giles-McCormick

Re: Proposal for Candidate Forum[s] in Flemington

Folks,

Seeing how this is an extremely important election with many significant issues facing Flemington, I propose all ...

Malinowski Supports NJ Infrastructure

To the editor,

I support Tom Malinowski in the election to represent New Jersey’s 7th district this November because he will support infrastructure investments that are essential to the continued prosperity of this district.

Tom recognizes this district’s dire need for infrastructure appropriations, and he knows how essential the Gateway Project is for not only those who commute ...

Upcoming Events

Sat, July 21, 1:00 PM

PetValu, Flemington

Greyhound Adoption Program Meet & Greet

Giving Back

Sat, July 21, 4:00 PM

Downtown Flemington, Flemington

Salsa Night

Arts & Entertainment

AtlantiCast

AtlantiCast: Episode 18

On this week’s AtlantiCast, you’ll find out how accessing care at Atlantic Health System is now easier, more affordable and closer to home than ever, learn which item from the produce aisle could be the newest weapon against cancer, see what Atlantic Health System, the New York Times and Instagram all have in common and much more.

 

 

Proposal for Flemington Candidates' Forum

July 17, 2018

To The editor,

This is an open note to Flemington Mayoral candidates Phil Greiner and Betsy Driver; and Borough Council candidates  Marc Hain, Brooke Warden, Chris Runion Caitlin Giles-McCormick

Re: Proposal for Candidate Forum[s] in Flemington

Folks,

Seeing how this is an extremely important election with many significant issues facing Flemington, I propose all ...

Notice of Hearing, Raritan Township

July 16, 2018

A public hearing will be held before the Raritan Township Zoning Board of Adjustment at the Municipal Building, located at 1 Municipal Drive in the  Committee/Court Meeting Room on Thursday July 19 at 7:30 p.m. on the following application: The above applicant is requesting approval of and any and all variances and waivers as may be required by the Board for an 28.56 kw Ground Mounted P.V.